
Dr Vaibhav Choudhary
Director — Medical & Precision Oncology
Nanavati Max Super Speciality Hospital, Mumbai
Experience: 19+ Years
Share Doctor Profile
Select Hospital
About Dr Vaibhav Choudhary
- Currently working at Nanavati Max Super Speciality Hospital, Mumbai (Apr 2025 – Present).
- Consultant – Medical Oncology, Kokilaben Hospital, Mumbai (Jan 2023 – Apr 2025).
- Consultant – Medical Oncology, American Oncology Institute, Nagpur (Jun 2022 – Jan 2023).
- Consultant – Medical Oncology, Wockhardt Hospitals, Nagpur (Oct 2019 – Jun 2022).
- Consultant & Head – Medical Oncology, HCG Cancer Centre, Nagpur (Mar 2018 – Oct 2019).
- Specialist Senior Resident – Medical Oncology, Tata Memorial Hospital, Mumbai (Aug 2015 – Jul 2016).
- Senior Resident – Medical Oncology, Tata Memorial Hospital, Mumbai (Aug 2012 – Jul 2015).
- Senior Resident – Medical Oncology, AIIMS IRCH, New Delhi (Sept 2011 - July 2012)
- Certification – Genetics & Precision Oncology, Cancer Immunotherapy & Gene Therapy, Harvard Medical School, Boston, US (2023).
- MRCP - Specialty Certificate in Medical Oncology (SCE) – Royal College of Physicians, UK, (2016).
- ESMO - (European Society for Medical Oncology), Certification in Medical Oncology, (2015).
- DM - Medical Oncology, Tata Memorial Hospital, Mumbai (2015).
- MD - General Medicine, All India Institute of Medical Sciences (AIIMS), New Delhi (2011).
- MBBS, Government Medical College, Nagpur (2007).
- American Society of Clinical Oncology (ASCO).
- European Society of Medical Oncology (ESMO).
- Indian Society of Medical and Pediatric Oncology (ISMPO).
- International Society of Liquid Biopsy (ISLB).
- Society for Immunotherapy of Cancer (SITC).
- Precision Oncology.
- Personalised Cancer Care.
- Systemic Treatment of all Forms of Cancer.
- Managing Relapsed and Refractory Stage 4 Cancer.
- Clinical Trials & Translational Research.
- “Efficacy and Safety of Biosimilar Cetuximab Versus Innovator Cetuximab in Indian Patients With Head and Neck Cancer: A Multicenter, Randomized, Double-Blind, Phase III Trial” – published in JCO Global Oncology (2024).
- “PDL1 Expression Testing in Head and Neck Squamous Cell Carcinoma: Bridging the Gap” – Indian Journal of Cancer (2023).
- “Evolution of Biomarkers and Treatment Outcomes of Immunotherapy in Lung Cancer in Current Tissue Microenvironment” – by Kaler A.K., Maskomani S., Ritambhara, Kavyashree, Varsha Vadera, Vaibhav Choudhary, Imran Shaikh, Sandeep Goyle & Rajesh Mistry (2023).
- “Comprehensive Genomic Profiling in Breast Cancer – Is it Ready for Prime Time Use?” – Choudhary V., Gupta S., published in Current Breast Cancer Reports (2016).
- “Targeted Therapy of Soft Tissue Sarcoma: There is More than One Way to Skin a Cat!” – Bajpai J., Choudhary V., in Chemo Open Access (2016).
- “Status of Cancer Research in India” IACR (2015).